Analysts think AVXL stock price could increase by 419%
Jun 09, 2025, 11:25 AM
23.37%
What does AVXL do
Anavex Life Sciences, a New York-based biopharmaceutical company, develops therapeutics for neurodegenerative diseases and employs 40 staff. Its lead compound, ANAVEX 2-73, targets Alzheimer's and Parkinson's diseases.
5 analysts think AVXL stock price will increase by 418.64%. The current median analyst target is $42.84 compared to a current stock price of $8.26. The lowest analysts target is $41.30 and the highest analyst target is $48.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
